Table 1 Clinicopathologic characteristics of the patients in the five HGG data sets
From: Clinical significance of FBXO17 gene expression in high-grade glioma
TCGA | Rembrandt 1b | Rembrandt 2c | GSE4271 | GSE4412 | |
|---|---|---|---|---|---|
No. of patientsa | 424 | 183 | 247 | 77 | 85 |
Age, median (range) | 58.9 (10.9–89.3) | 50 (20–80) | 50 (15–80) | 45 (22–82) | 42 (18–82) |
Sex | |||||
Female | 159 (37.5) | 47 (36.4) | 67 (38.5) | 25 (32.5) | 53 (62.4) |
Male | 265 (62.5) | 82 (63.6) | 107 (61.5) | 52 (67.5) | 32(37.6) |
NA | 0 | 54 | 73 | 0 | 0 |
Grade | |||||
III | 0 (0) | 0 (0) | 64 (25.9) | 21 (27.3) | 26 (30.6) |
IV (GBM) | 424 (100) | 183 (100) | 183 (74.1) | 56 (72.7) | 59 (69.4) |
Vital Status | |||||
Alive | 75 (17.7) | 10 (5.5) | 21 (8.5) | 15 (19.5) | 26 (30.6) |
Dead | 349 (82.3) | 173 (94.5) | 226 (91.5) | 62 (80.5) | 59 (69.4) |
Median OS in months | 14.2 | 15 | 16 | 23.8 | 13.9 |